Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

Peptides

Items 21-30 of 45

Page
per page
  1. Amyloid Beta-peptide (25-35) (human)
    A1039 Amyloid Beta-peptide (25-35) (human)
     1 Citation
    Summary: Functional domain of Aβ
      insoluble in EtOH; insoluble in H2O; ≥106 mg/mL
  2. PalMitoyl Tripeptide-1
    B6053 PalMitoyl Tripeptide-1
      insoluble in DMSO; insoluble in EtOH; insoluble in H2O
  3. Amyloid β-Peptide (1-42) (human)
    B6057 Amyloid β-Peptide (1-42) (human)
     2 Citation
      insoluble in H2O; insoluble in EtOH; ≥40.5 mg/mL
  4. NGR peptide
    B1434 NGR peptide
    Summary: Cell-penetrating peptide
      insoluble in EtOH; ≥20.3 mg/mL
  5. G-Protein antagonist peptide
    B6889 G-Protein antagonist peptide
    Summary: Inhibits G protein activation by GPCRs
      Soluble to 2 mg/mL
  6. RGDS peptide
    B7412 RGDS peptide
    Summary: Integrin binding sequence that inhibits integrin receptor function
      ≥21.65 mg/mL
  7. Akt/SKG Substrate Peptide
    B5101 Akt/SKG Substrate Peptide
    Summary: substrate for Akt/PKB
      Soluble to 1 mg/mL
  8. MLCK inhibitor peptide 18
    B5211 MLCK inhibitor peptide 18
    Summary: A cell-permeable inhibitor with high selectivity for myosin light chain kinase (MLCK)
      ≥58.5 mg/mL
  9. Atrial natriuretic factor (1-28) (rat)
    B5227 Atrial natriuretic factor (1-28) (rat)
    Summary: Endogenous peptide involved in blood pressure regulation
      ≥45.3 mg/mL
  10. Eledoisin-Related Peptide
    B5233 Eledoisin-Related Peptide
    Summary: Tachykinin receptor ligand

Items 21-30 of 45

Page
per page